Renaissance Technologies’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.79M Sell
1,972,335
-319,046
-14% -$290K ﹤0.01% 2179
2025
Q1
$1.03M Buy
2,291,381
+8,309
+0.4% +$3.75K ﹤0.01% 2409
2024
Q4
$1.15M Buy
2,283,072
+2,085,972
+1,058% +$1.05M ﹤0.01% 2422
2024
Q3
$178K Sell
197,100
-386,522
-66% -$350K ﹤0.01% 3146
2024
Q2
$582K Buy
583,622
+53,022
+10% +$52.9K ﹤0.01% 2625
2024
Q1
$785K Buy
530,600
+380,600
+254% +$563K ﹤0.01% 2639
2023
Q4
$164K Buy
150,000
+90,300
+151% +$98.7K ﹤0.01% 3193
2023
Q3
$70K Buy
59,700
+3,800
+7% +$4.46K ﹤0.01% 3321
2023
Q2
$79K Buy
+55,900
New +$79K ﹤0.01% 3520
2021
Q1
Sell
-23,000
Closed -$40K 3532
2020
Q4
$40K Sell
23,000
-437,806
-95% -$761K ﹤0.01% 3327
2020
Q3
$432K Sell
460,806
-30,894
-6% -$29K ﹤0.01% 2867
2020
Q2
$428K Buy
491,700
+223,300
+83% +$194K ﹤0.01% 2924
2020
Q1
$222K Buy
+268,400
New +$222K ﹤0.01% 3077
2019
Q1
Sell
-259,300
Closed -$237K 3587
2018
Q4
$237K Buy
+259,300
New +$237K ﹤0.01% 3092
2018
Q3
Sell
-166,421
Closed -$300K 3459
2018
Q2
$300K Sell
166,421
-721,004
-81% -$1.3M ﹤0.01% 2960
2018
Q1
$2.09M Sell
887,425
-481,660
-35% -$1.13M ﹤0.01% 2306
2017
Q4
$2.58M Buy
1,369,085
+922,972
+207% +$1.74M ﹤0.01% 2190
2017
Q3
$1.11M Buy
446,113
+302,544
+211% +$751K ﹤0.01% 2541
2017
Q2
$396K Buy
143,569
+22,614
+19% +$62.4K ﹤0.01% 2827
2017
Q1
$365K Buy
+120,955
New +$365K ﹤0.01% 2858
2015
Q3
Sell
-204,437
Closed -$599K 3269
2015
Q2
$599K Buy
+204,437
New +$599K ﹤0.01% 2668
2014
Q2
Sell
-64,057
Closed -$170K 2876
2014
Q1
$170K Buy
+64,057
New +$170K ﹤0.01% 2644